JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2008, 57(2):70-77

Radiolabelled peptides in the diagnosis and therapy of tumours

J. Cihlo, M. Lázníček*
Univerzita Karlova v Praze, Farmaceutická fakulta v Hradci Králové, katedra farmakologie a toxikologie

In the last two decades, radiolabelled receptor-specific peptides have profiled themselves as excellent tools that have expressively increased the diagnostic and therapeutical possibilities of tumours predominantly of neuroendocrine origin. The aim of this review paper is to transparently inform the Czech scientific fraternity about the significance and limitations of the use of this group of radiopharmaceuticals in clinical practice.

Keywords: radiopharmaceuticals; diagnosis; therapy; cancers; receptor-specific peptides
Grants and funding:

Tato práce byla podpořena grantem č. 305/07/0535 Grantové agentury České republiky.

Received: January 10, 2007; Accepted: January 31, 2008; Published: February 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Cihlo J, Lázníček M. Radiolabelled peptides in the diagnosis and therapy of tumours. Čes. slov. farm. 2008;57(2):70-77.
Download citation

References

  1. Reubi, J. C.: Endocr. Rev., 2003; 24, 389-427. Go to original source... Go to PubMed...
  2. de Herder, W. W., Lamberts, S. W.: Curr. Opin. Oncol., 2002; 14, 53-57. Go to original source... Go to PubMed...
  3. Lamberts, S. W., de Herder, W. W., Hofland, L. J.: Trends Endocrinol. Metab., 2002; 13, 451-457. Go to original source... Go to PubMed...
  4. Behr, T. M., Behe, M., Becker, W.: Q. J. Nucl. Med., 1999; 43, 268-280.
  5. de Visser, M., Janssen, P. J., Srinivasan, A. et al.: Eur. J. Nucl. Med. Mol. Imaging, 2003; 30, 1134-1139. Go to original source... Go to PubMed...
  6. Koikov, L. N., Ebetino, F. H., Solinsky, M. G. et al.: Bioorg. Med. Chem. Lett., 2003; 13, 2647-2650. Go to original source... Go to PubMed...
  7. Reubi, J. C., Waser, B., Schaer, J. C., Laissue, J. A.: Eur. J. Nucl. Med., 2001; 28, 836-846. Go to original source... Go to PubMed...
  8. Weiner, R. E.,Thakur, M. L.: BioDrugs, 2005; 19, 145-163. Go to original source... Go to PubMed...
  9. Breeman, W. A., Kwekkeboom, D. J., de Blois, E. et al.: Anticancer Agents Med. Chem., 2007; 7, 345-357. Go to original source... Go to PubMed...
  10. Patel, Y. C., Greenwood, M. T., Panetta, R. et al.: Life Sci., 1995; 57, 1249-1265. Go to original source... Go to PubMed...
  11. Scherubl, H., Hescheler, J.,Riecken, E. O.: Horm. Metab. Res. Suppl., 1993; 27, 1-4.
  12. Reubi, J. C.: Neuroendocrinology, 2004; 80 (Suppl. 1), 51-56. Go to original source... Go to PubMed...
  13. Blok, D., Feitsma, R. I., Vermeij, P., Pauwels, E. J.: Eur. J. Nucl. Med., 1999; 26, 1511-1519. Go to original source... Go to PubMed...
  14. Hejna, M., Schmidinger, M., Raderer, M.: Ann. Oncol., 2002; 13, 653-668. Go to original source... Go to PubMed...
  15. Gotthardt, M., Boermann, O. C., Behr, T. M. et al.: Curr. Pharm. Des., 2004; 10, 2951-2963. Go to original source... Go to PubMed...
  16. Breeman, W. A., de Jong, M., Kwekkeboom, D. J. et al.: Eur. J. Nucl. Med., 2001; 28, 1421-1429. Go to original source... Go to PubMed...
  17. Wild, D., Schmitt, J. S., Ginj, M. et al.: Eur. J. Nucl. Med. Mol. Imaging, 2003; 30, 1338-1347. Go to original source... Go to PubMed...
  18. Virgolini, I., Traub, T., Novotny, C. et al.: Curr. Pharm. Des., 2002; 8, 1781-1807. Go to original source... Go to PubMed...
  19. Decristoforo, C., Maina, T., Nock, B. et al.: Eur. J. Nucl. Med. Mol. Imaging, 2003; 30, 1211-1219. Go to original source... Go to PubMed...
  20. Kopecky, M., Trejtnar, F., Laznicek, M. et al.: Nucl. Med. Commun., 2005; 26, 549-554. Go to original source... Go to PubMed...
  21. Maina, T., Nock, B., Nikolopoulou, A. et al.: Eur. J. Nucl. Med. Mol. Imaging, 2002; 29, 742-753. Go to original source... Go to PubMed...
  22. Maina, T., Nock, B. A., Cordopatis, P. et al.: Eur. J. Nucl. Med. Mo. Imaging, 2006; 33, 831-840. Go to original source... Go to PubMed...
  23. Decristoforo, C., Mather, S. J., Cholewinski, W. et al.: Eur. J. Nucl. Med., 2000; 27, 1318-1325. Go to original source... Go to PubMed...
  24. Decristoforo, C., Melendez-Alafort, L., Sosabowski, J. K., Mather, S. J.: J. Nucl. Med., 2000; 41, 1114-1119.
  25. Cremonesi, M., Ferrari, M., Bodei, L. et al.: J. Nucl. Med., 2006; 47, 1467-1475.
  26. de Jong, M., Breeman, W. A., Bernard, B. F. et al.: Int. J. Cancer, 2001; 92, 628-633. Go to original source...
  27. Lewis, J. S., Wang, M., Laforest, R. et al.: Int. J. Cancer, 2001; 94, 873-877. Go to original source... Go to PubMed...
  28. Bugaj, J. E., Erion, J. L., Johnson, M. A. et al.: Nucl. Med. Biol., 2001; 28, 327-334. Go to original source... Go to PubMed...
  29. Cyr, J. E., Pearson, D. A., Wilson, D. M. et al.: J. Med. Chem., 2007; 50, 1354-1364. Go to original source... Go to PubMed...
  30. Lewis, J. S., Lewis, M. R., Cutler, P. D. et al.: Clin. Cancer Res., 1999; 5, 3608-3616.
  31. Lewis, J. S., Srinivasan, A., Schmidt, M. A., Anderson, C. J.: Nucl. Med. Biol., 1999; 26, 267-273. Go to original source... Go to PubMed...
  32. Blower, P.: Dalton Trans, 2006; 1705-1711. Go to original source... Go to PubMed...
  33. Lister-James, J., Moyer, B. R.,Dean, R. T.: Q. J. Nucl. Med., 1997; 41, 111-118. Go to original source...
  34. Kaltsas, G. A., Papadogias, D., Makras, P., Grossman, A. B.: Endocr. Relat. Cancer, 2005; 12, 683-699. Go to original source... Go to PubMed...
  35. Caplin, M. E., Buscombe, J. R., Hilson, A. J. et al.: Lancet, 1998; 352, 799-805. Go to original source... Go to PubMed...
  36. Gibril, F., Reynolds, J. C., Doppman, J. L. et al.: Ann. Intern. Med., 1996; 125, 26-34. Go to original source... Go to PubMed...
  37. Cremonesi, M., Ferrari, M., Bodei, L. et al.: Q. J. Nucl. Med. Mol. Imaging, 2006; 50, 288-295.
  38. Forrer, F., Valkema, R., Kwekkeboom, D. J. et al.: Best. Pract. Res. Clin. Endocrinol. Metab, 2007; 21, 111-129. Go to original source... Go to PubMed...
  39. Teunissen, J. J., Kwekkeboom, D. J., de Jong, M. et al.: Best. Pract. Res. Clin. Gastroenterol., 2005; 19, 595-616. Go to original source... Go to PubMed...
  40. Capello, A., Krenning, E. P., Breeman, W. A. et al.: J. Nucl. Med., 2003; 44, 98-104.
  41. de Jong, M., Bakker, W. H., Krenning, E. P. et al.: Eur. J. Nucl. Med., 1997; 24, 368-371. Go to original source... Go to PubMed...
  42. Krenning, E. P., de Jong, M., Kooij, P. P. et al.: Ann. Oncol., 1999; 10 (Suppl. 2), S23-S29. Go to original source... Go to PubMed...
  43. Anderson, C. J., Dehdashti, F., Cutler, P. D. et al.: J. Nucl. Med., 2001; 42, 213-221.
  44. Kwekkeboom, D. J., Bakker, W. H., Kooij, P. P. et al.: Eur. J. Nucl. Med., 2001; 28, 1319-1325. Go to original source... Go to PubMed...
  45. Deutsch, E., Libson, K., Vanderheyden, J. L. et al.: Int. J. Rad. Appl. Instrum. B, 1986; 13, 465-477. Go to original source... Go to PubMed...
  46. Cremonesi, M., Ferrari, M., Zoboli, S. et al.: Eur. J. Nucl. Med., 1999; 26, 877-886. Go to original source... Go to PubMed...
  47. Pauwels, S., Barone, R., Walrand, S. et al.: J. Nucl. Med., 2005; 46 (Suppl. 1), 92S-98S.
  48. Engstrom, P. F., Lavin, P. T., Moertel, C. G. et al.: J. Clin. Oncol., 1984; 2, 1255-1259. Go to original source... Go to PubMed...
  49. Bodei, L., Cremonesi, M., Zoboli, S. et al.: Eur. J. Nucl. Med. Mol. Imaging, 2003; 30, 207-216. Go to original source... Go to PubMed...
  50. Barone, R., Borson-Chazot, F., Valkema, R. et al.: J. Nucl. Med., 2005; 46 (Suppl. 1), 99S-106S.
  51. Rolleman, E. J., Valkema, R., de Jong, M. et al.: Eur. J. Nucl. Med. Mol. Imaging, 2003; 30, 9-15. Go to original source... Go to PubMed...
  52. van Eerd, J. E., Vegt, E., Wetzels, J. F. et al.: J. Nucl. Med., 2006; 47, 528-533.
  53. Vegt, E., Wetzels, J. F., Russel, F. G. et al.: J. Nucl. Med., 2006; 47, 432-436.
  54. Behe, M., Kluge, G., Becker, W. et al.: J. Nucl. Med., 2005; 46, 1012-1015.
  55. Gotthardt, M., van Eerd-Vismale, J., Oyen, W. J. et al.: J. Nucl. Med., 2007; 48, 596-601. Go to original source... Go to PubMed...
  56. Barone, R., Van Der Smissen, P., Devuyst, O. et al.: Kidney Int., 2005; 67, 969-976. Go to original source... Go to PubMed...
  57. de Jong, M., Barone, R., Krenning, E. et al.: J. Nucl. Med., 2005; 46, 1696-1700.
  58. Melis, M., Krenning, E. P., Bernard, B. F. et al.: Eur. J. Nucl. Med. Mol. Imaging, 2005; 32, 1136-1143. Go to original source... Go to PubMed...
  59. Christensen, E. I., Nielsen, R.: Rev. Physiol. Biochem. Pharmacol., 2007; 158, 1-22.
  60. Christensen, E. I.,Verroust, P. J.: Pediatr. Nephrol., 2002; 17, 993-999. Go to original source... Go to PubMed...
  61. Verroust, P. J.,Christensen, E. I.: Nephrol. Dial. Transplant., 2002; 17, 1867-1871. Go to original source... Go to PubMed...
  62. Moestrup, S. K., Cui, S., Vorum, H. et al.: J. Clin. Invest., 1995; 96, 1404-1413. Go to original source... Go to PubMed...
  63. Rolleman, E. J., Forrer, F., Bernard, B. et al.: Eur. J. Nucl. Med. Mol. Imaging, 2007; 34, 763-771. Go to original source... Go to PubMed...
  64. Bodei, L., Cremonesi, M., Grana, C. et al.: Eur. J. Nucl. Med. Mol. Imaging, 2004; 31, 1038-1046. Go to original source... Go to PubMed...
  65. de Jong, M., Valkema, R., Jamar, F. et al.: Semin. Nucl. Med., 2002; 32, 133-140. Go to original source... Go to PubMed...
  66. Reubi, J. C.,Waser, B.: Eur. J. Nucl. Med. Mol. Imaging, 2003; 30, 781-793. Go to original source... Go to PubMed...
  67. Reubi, C., Gugger, M., Waser, B.: Eur. J. Nucl. Med. Mol. Imaging, 2002; 29, 855-862. Go to original source... Go to PubMed...
  68. van Hagen, P. M., Breeman, W. A., Bernard, H. F. et al.: Int. J. Cancer, 2000; 90, 186-198. Go to original source...
  69. Schumacher, T., Hofer, S., Eichhorn, K. et al.: Eur. J. Nucl. Med. Mol. Imaging, 2002; 29, 486-493. Go to original source... Go to PubMed...




Czech and Slovak Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.